Milan - Delayed Quote EUR
Vertex Pharmaceuticals Incorporated (1VRTX.MI)
438.15
+7.00
+(1.62%)
As of April 10 at 1:09:49 PM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ALTSHULER DAVID Officer | Sale | Mar 13, 2025 | 23,281 |
AMBROSE KRISTEN Officer | Sale | Feb 25, 2025 | 9,086 |
ARBUCKLE STUART A Chief Operating Officer | Stock Award(Grant) | Feb 12, 2025 | 77,586 |
ATKINSON EDWARD MORROW III Chief Technology Officer | Sale | Feb 27, 2025 | 19,352 |
BILLER JONATHAN PRIM Officer | Sale | Feb 18, 2025 | 17,606 |
BOZIC CARMEN Officer | Stock Award(Grant) | Feb 12, 2025 | 42,853 |
KEWALRAMANI RESHMA Chief Executive Officer | Stock Award(Grant) | Feb 12, 2025 | 135,933 |
SACHDEV AMIT Officer | Stock Award(Grant) | Feb 12, 2025 | 77,684 |
TATSIS OURANIA Officer | Sale | Mar 10, 2025 | 51,239 |
WAGNER CHARLES F JR Chief Financial Officer | Sale | Mar 10, 2025 | 51,671 |
Related Tickers
ICY.F Incyte Corporation
50.88
+0.24%
RGO.F Regeneron Pharmaceuticals, Inc.
512.20
-0.62%
GALT Galectin Therapeutics Inc.
1.3400
+0.75%
PROK ProKidney Corp.
0.9101
+21.49%
ACHV Achieve Life Sciences, Inc.
2.4300
-2.02%
ONVO Organovo Holdings, Inc.
2.0400
+1.49%
TIL Instil Bio, Inc.
20.52
+24.44%
CMND Clearmind Medicine Inc.
0.9764
-2.36%
INCY Incyte Corporation
58.00
+1.08%
ATAI Atai Life Sciences N.V.
1.5200
+3.40%